Search AMIA.org

CURATE.AI is an artificial intelligence platform enabling personalised drug dosing. Aims:1) Determine the feasibility of using CURATE.AI in the outpatient setting.2) Compare the consistency of CURATE.AI recommendations derived from different data sources.3) Assess the alignment of physician and CURATE.AI dosing recommendations.

Electronic health records (EHRs) rarely capture dietary detail, limiting diet-disease research. We aimed to develop machine learning (ML) computable phenotypes to identify high-fat diet (HFD) using variables typically available in EHRs.

The COVID-19 pandemic has highlighted the growing reliance on machine learning (ML) models for predicting disease severity, which is important for clinical decision-making and equitable resource allocation. While achieving high predictive accuracy is important, ensuring fairness in the prediction output of these models is equally important to prevent bias-driven disparities in healthcare. This study evaluates fairness in a machine learning-based COVID-19 severity classification model and proposes an Explainable AI (XAI)-based [...]

The surge in publications increases screening time required to maintain high-quality literature reviews. One of the most time-consuming phases is title and abstract screening. Machine learning tools have semi-automated this process for systematic reviews, with limited success for scoping reviews. ChatGPT, a chatbot based on a large language model, might support scoping review screening by identifying key concepts and themes. We hypothesize that ChatGPT outperforms the semi-automated tool Rayyan, increasing [...]

To describe a health system's experience administering patient-reported outcome measures (PROMs) to patients with a non-English preferred language (NEPL).

We sought to compare and analyze the performance of a medication knowledge base (MKB) vendor's (Medi-Span) fully enabled, factory settings product to operational implementations in hospitals using the Leapfrog Group's Computerized Physician Order Entry (CPOE)/electronic health record (EHR) Evaluation Tool.

To explore the use of large language models (LLMs) to assist in developing new agent-based disease-specific patient journey models.

The increasing volume of clinical trial documents presents a significant challenge for biomedical researchers who must analyze vast amounts of unstructured and structured data. Traditional methods are no longer feasible given the scale and complexity of modern clinical trials.

To describe the process of updating the Patient Identification Safety Assurance Factors for EHR Resilience (SAFER) Guide and to review new practices and refinements to the Guide.

Management of patients with vestibular schwannoma (VS) relies on precise tumor size and growth trend evaluation. We introduce and evaluate a novel computer-assisted reporting tool for clinical decision support during multidisciplinary team meetings (MDTMs) for VS patients.